Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE: 300832)

Market Cap	53.00B
Revenue (ttm)	4.28B
Net Income (ttm)	1.81B
Shares Out	785.72M
EPS (ttm)	2.30
PE Ratio	29.33
Forward PE	23.58
Dividend	1.00 (1.49%)
Ex-Dividend Date	May 15, 2024

Volume	1,858,765
Open	67.65
Previous Close	67.25
Day's Range	66.66 - 68.15
52-Week Range	58.31 - 83.50
Beta	-0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Shenzhen New Industries Biomedical Engineering

Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in the People's Republic of China and internationally. It offers immunoassay, biochemistry/electrolyte, molecular diagnostics, point of care testing, lab automation, and integrated system, products. The company was founded in 1995 and is headquartered in Shenzhen, the People's Republic of China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,627
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2023, Shenzhen New Industries Biomedical Engineering's revenue was 3.93 billion, an increase of 28.97% compared to the previous year's 3.05 billion. Earnings were 1.65 billion, an increase of 24.53%.